Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Columbia University Medical Center, New York, New York, USA.
Center for Innovation and Outcomes Research, Columbia University, New York, New York, USA.
Clin Transplant. 2021 Nov;35(11):e14458. doi: 10.1111/ctr.14458. Epub 2021 Sep 12.
In 2018, the United Network for Organ Sharing (UNOS) introduced new criteria for heart allocation. This study sought to assess the impact of this change on waitlist and posttransplant outcomes in adult congenital heart disease (ACHD) recipients.
Between January 2010 and March 2020, we extracted first heart transplant ACHD patients listed from the UNOS database. We compared waitlist and post-transplant outcomes before and after the policy change.
A total of 1206 patients were listed, 951 under the old policy and 255 under the new policy. Prior to transplant, recipients under the new policy era were more likely to be treated with extracorporeal membrane oxygenation (P = .018), and have intra-aortic balloon pumps (P < .001), and less likely to have left ventricular assist devices (P = .027).Compared to patients waitlisted in the pre-policy change era, those waitlisted in the post policy change era were more likely to receive transplants (P = .001) with no significant difference in waiting list mortality (P = .267) or delisting (P = .915). There was no difference in 1-year survival post-transplant between the groups (P = .791).
The new policy altered the heart transplant cohort in the ACHD group, allowing them to receive transplants earlier with no changes in early outcomes after heart transplantation.
2018 年,美国器官共享联合网络(UNOS)引入了新的心脏分配标准。本研究旨在评估这一变化对成人先天性心脏病(ACHD)受者等待名单和移植后结局的影响。
在 2010 年 1 月至 2020 年 3 月期间,我们从 UNOS 数据库中提取了首次心脏移植的 ACHD 患者名单。我们比较了政策变化前后的等待名单和移植后结局。
共有 1206 名患者被列入名单,951 名患者在旧政策下,255 名患者在新政策下。在移植前,新政策时代的受者更有可能接受体外膜肺氧合治疗(P=0.018),更有可能使用主动脉内球囊泵(P<0.001),而不太可能使用左心室辅助装置(P=0.027)。与政策变化前等待名单上的患者相比,政策变化后等待名单上的患者更有可能接受移植(P=0.001),但等待名单死亡率(P=0.267)或除名(P=0.915)无显著差异。两组患者移植后 1 年生存率无差异(P=0.791)。
新政策改变了 ACHD 组的心脏移植队列,使他们能够更早地接受移植,而心脏移植后的早期结局没有变化。